Here’s the latest research news: a commonly prescribed medication for back pain — especially Gabapentin — has been linked to a higher risk of dementia and cognitive decline in a large observational study. (BMJ)
🧠 What the New Study Found
- Researchers analyzed tens of thousands of medical records of adults with chronic lower back pain.
- People who had six or more prescriptions for gabapentin were found to have:
- ~29% higher risk of dementia
- ~85% higher risk of mild cognitive impairment (MCI)
over about a decade compared with similar patients not prescribed the drug. (BMJ)
📊 Who Was Studied?
- Adults with chronic back pain or nerve pain
- Both older and younger adults (even ages 35–49 were affected)
- Matched with controls who had pain but did not use gabapentin
Findings showed elevated dementia and cognitive risk in the medication group. (BMJ)
🧪 Important Clarifications
- This study shows an association, not proof of cause — meaning gabapentin use may be linked to higher dementia risk, but it doesn’t prove the drug directly causes dementia. Other factors may contribute.
- “Observational” research can suggest risk patterns, but doesn’t establish direct cause-and-effect. (RTTNews)
🧠 What Experts Recommend
- Discuss treatment options with your doctor if you’re on gabapentin long‑term
- Be especially mindful if you have other cognitive risk factors (age, family history, diabetes, etc.)
- Do not stop the medication abruptly — stopping any prescription should only be done under medical supervision
🩺 Bottom Line
A new large study suggests that frequent prescriptions of a common back pain and nerve pain drug (gabapentin) may be linked to a higher risk of dementia or mild cognitive impairment over time, especially with long-term use. This doesn’t prove the drug causes dementia, but it does reinforce the need for careful monitoring and discussion with a healthcare professional when using it regularly. (BMJ)
If you want, I can break this down into a simple risk‑vs‑benefit explanation of pain meds and brain health so it’s easier to understand which medications are safer long‑term. Would you like that?
